CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome
Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
A Phase II, multicenter, double blind, double dummy, randomized, 2 arms parallel study to
evaluate the efficacy, safety and pharmacokinetics of CHF6563 in babies with Neonatal Opioid
Withdrawal Syndrome